|
FY2018
12 months to Sep 30, 2018
|
FY2017
12 months to Sep 30, 2017
|
FY2016
12 months to Sep 30, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
9 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Successor | |||||
| Total net loss | |||||
| Decrease/(Increase) in prepaid expenses | |||||
| Increase/(Decrease) in accrued state franchise tax | |||||
| Increase/(Decrease) in accrued expenses | |||||
| Accrued interest on Sponsor convertible note | |||||
| Amortization of original issue discount | |||||
| Interest on investments | |||||
| Cash flows from operations | |||||
| Net income (loss) from continuing operations | |||||
| Successor | |||||
| Total net income (loss) from continuing operations | |||||
| Adjustments to reconcile to cash flows from operations: | |||||
| Depreciation and amortization | |||||
| Successor | |||||
| Total depreciation and amortization | |||||
| Debt issuance costs amortization, debt issuance costs write-offs and original issue discount amortization | |||||
| Successor | |||||
| Total debt issuance costs amortization, debt issuance costs write-offs and original issue discount amortization | |||||
| Non-cash transaction costs | |||||
| Successor | |||||
| Total non-cash transaction costs | |||||
| Provision for bad debt | |||||
| Successor | |||||
| Total provision for bad debt | |||||
| Inventory impairment | |||||
| Successor | |||||
| Total inventory impairment | |||||
| Impairment charge due to natural disasters | |||||
| Deferred income taxes | |||||
| Successor | |||||
| Total deferred income taxes | |||||
| Equity-based compensation expense | |||||
| Successor | |||||
| Total equity-based compensation expense | |||||
| Change in fair value of contingent consideration obligations | |||||
| Successor | |||||
| Total change in fair value of contingent consideration obligations | |||||
| (Gain) loss from sales of property and equipment | |||||
| Successor | |||||
| Total (Gain) loss from sales of property and equipment | |||||
| Gain related to reimbursements of certain capital expenditures incurred | |||||
| Successor | |||||
| Total gain related to reimbursements of certain capital expenditures incurred | |||||
| Gain from proceeds of insurance claim | |||||
| Gain from debt extinguishment, net | |||||
| Successor | |||||
| Total gain from debt extinguishment, net | |||||
| Foreign currency gain on purchase of additional equity interest in Nexeo Plaschem | |||||
| Changes in assets and liabilities: | |||||
| Accounts and notes receivable | |||||
| Successor | |||||
| Total accounts and notes receivable | |||||
| Inventories | |||||
| Successor | |||||
| Total inventories | |||||
| Other current assets | |||||
| Successor | |||||
| Total other current assets | |||||
| Accounts payable | |||||
| Successor | |||||
| Total accounts payable | |||||
| Related party payable | |||||
| Successor | |||||
| Total related party payable | |||||
| Accrued expenses and other liabilities | |||||
| Successor | |||||
| Total accrued expenses and other liabilities | |||||
| Changes in other operating assets and liabilities, net | |||||
| Successor | |||||
| Total changes in other operating assets and liabilities, net | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Successor | |||||
| Total net cash provided by operating activities from continuing operations | |||||
| Withdrawal of trust account funds for payment of Delaware franchise tax | |||||
| Proceeds deposited into trust account for investments | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Successor | |||||
| Total net cash provided by operating activities from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Successor | |||||
| Total net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Additions to property and equipment | |||||
| Successor | |||||
| Total additions to property and equipment | |||||
| Proceeds from the disposal of property and equipment | |||||
| Successor | |||||
| Total proceeds from the disposal of property and equipment | |||||
| Proceeds from reimbursement for certain capital expenditures incurred | |||||
| Successor | |||||
| Total proceeds from reimbursement for certain capital expenditures incurred | |||||
| Insurance proceeds related to property and equipment | |||||
| Proceeds withdrawn from trust account | |||||
| Successor | |||||
| Total proceeds withdrawn from trust account | |||||
| Net cash provided by (used in) investing activities from continuing operations | |||||
| Successor | |||||
| Total net cash provided by (used in) investing activities from continuing operations | |||||
| Proceeds from sale of common stock to Sponsor | |||||
| Proceeds from sale of common stock through public offering | |||||
| Proceeds from Sponsor to purchase private placement warrants | |||||
| Proceeds from note payable - related party | |||||
| Payment of underwriting discounts | |||||
| Payment of accrued formation and offering costs | |||||
| Net cash provided by investing activities from discontinued operations | |||||
| Cash paid for asset and business acquisitions | |||||
| Successor | |||||
| Total cash paid for asset and business acquisitions | |||||
| Net cash provided by (used in) investing activities | |||||
| Successor | |||||
| Total net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock | |||||
| Successor | |||||
| Total proceeds from issuance of common stock | |||||
| Redemption of common stock | |||||
| Successor | |||||
| Total redemption of common stock | |||||
| Proceeds from Sponsor convertible note and Sponsor promissory note | |||||
| Successor | |||||
| Total proceeds from Sponsor convertible note and Sponsor promissory note | |||||
| Repayment of Sponsor convertible note and Sponsor promissory note | |||||
| Successor | |||||
| Total repayment of Sponsor convertible note and Sponsor promissory note | |||||
| Repurchases of membership units | |||||
| Successor | |||||
| Total repurchases of membership units | |||||
| Tax distributions associated with membership interests | |||||
| Successor | |||||
| Total tax distributions associated with membership interests | |||||
| Purchase of additional noncontrolling equity interest in Nexeo Plaschem | |||||
| Successor | |||||
| Total purchase of additional noncontrolling equity interest in Nexeo Plaschem | |||||
| Cash paid to TPG related to TRA | |||||
| Proceeds from short-term debt | |||||
| Successor | |||||
| Total proceeds from short-term debt | |||||
| Repayments of short-term debt | |||||
| Successor | |||||
| Total repayments of short-term debt | |||||
| Proceeds from issuance of long-term debt | |||||
| Successor | |||||
| Total proceeds from issuance of long-term debt | |||||
| Repayments of long-term debt and capital lease obligations | |||||
| Successor | |||||
| Total repayments of long-term debt and capital lease obligations | |||||
| Repayment of Predecessor long-term debt | |||||
| Successor | |||||
| Total repayment of Predecessor long-term debt | |||||
| Payments of debt issuance costs | |||||
| Successor | |||||
| Total payments of debt issuance costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Successor | |||||
| Total net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Successor | |||||
| Total effect of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Successor | |||||
| Total increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Successor | |||||
| Predecessor | |||||
| Total cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Successor | |||||
| Total cash and cash equivalents at the end of the period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Successor | |||||
| Total cash paid during the period for interest | |||||
| Cash paid during the period for taxes (net of refunds) | |||||
| Successor | |||||
| Total cash paid during the period for taxes (net of refunds) | |||||
| Non-cash payment of deferred underwriting fees | |||||
| Successor | |||||
| Total non-cash payment of deferred underwriting fees | |||||
| Supplemental disclosure of non-cash investing and non-cash financing activities: | |||||
| Deferred underwriting compensation | |||||
| Non-cash capital expenditures | |||||
| Successor | |||||
| Total non-cash capital expenditures | |||||
| Non-cash intangible assets acquired | |||||
| Non-cash capital lease obligations, net | |||||
| Successor | |||||
| Total non-cash capital lease obligations, net | |||||
Loading...